Cello Health acquires US consulting firm ISS

Cello Health has expanded its US footprint with the acquisition of New Jersey-based scientific consulting firm Innovative Science Solutions (ISS).

Founded nearly 20 years ago by Steven Weisman and David Schwartz, ISS specialises in strategic regulatory support for the healthcare industry and scientific support on health-related issues for legal counsel.

Stephen Highley (pictured above), chairman of Cello Health, said: " ISS has achieved a strong reputation for provision of its scientific consulting services, and the specificity of these technical services is a perfect addition to Cello’s focus on supporting client’s along the most critical drug development and successful commercialisation pathways.”

ISS’ offering includes consultancy at all stages in the regulatory process, support of FDA Advisory Committee meetings and data provision in legal defense of patent and intellectual property issues.

Julia Ralston (pictured above), CEO at Cello Health US, said: “The acquisition of ISS is an excellent strategic fit as we continue our expansion in the US. We are excited about how the clear synergies between this new offer and our existing capabilities will benefit Cello Health’s clients and our work tackling their biggest challenges in navigating scientific, commercial, and regulatory approaches that increase an asset’s market potential.”